TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma-Reference-Cited by-同舟云学术

TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma

Published:2015-04-24 Issue:11 Volume:35 Page:2466-2473
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Sciarra Amedeo¹,Ronot Maxime²,Di Tommaso Luca¹,Raschioni Carlotta¹,Castera Laurent³,Belghiti Jacques⁴,Bedossa Pierre⁵,Vilgrain Valérie²,Roncalli Massimo¹,Paradis Valérie⁵

Affiliation:

1. Pathology Department; Humanitas clinical and Research Center and University of Milan School of Medicine; Milan Italy

2. Radiology Department; Beaujon Hospital; Clichy 92110 France

3. Hepatology Department; Beaujon Hospital; Clichy 92110 France

4. Liver Surgery and Transplantation Department; Beaujon Hospital; Clichy 92110 France

5. Pathology Department; Beaujon Hospital; Clichy 92110 France

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12844/fullpdf

Reference31 articles.

1. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999

2. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

3. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma;Decaens;Liver Transpl,2005

4. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis;Majno;Ann Surg,1997

5. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria;Ravaioli;Am J Transplant,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma;Computers in Biology and Medicine;2024-05

2. Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology;Hepatology;2023-07-03

3. Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation;Scientific Data;2023-01-18

4. Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features;BMC Medical Imaging;2022-10-07

5. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis;Clinical and Experimental Medicine;2022-06-23